COVID-linked multi-system inflammatory syndrome in children diagnosed more in Black and Latino child
(Children's National Hospital) Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children's National Hospital in Washington, D.C. Researchers also found cardiac complications, including systolic myocardial dysfunction and valvular regurgitation, were more common in MIS-C patients who were critically ill. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 25, 2021 Category: Infectious Diseases Source Type: news

When did the first COVID-19 case arise?
(PLOS) Using methods from conservation science, a new analysis suggests that the first case of COVID-19 arose between early October and mid-November, 2019 in China, with the most likely date of origin being November 17. David Roberts of the University of Kent, U.K., and colleagues present these findings in the open-access journal PLOS Pathogens. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Uncovered: Crucial insight into how Ebola virus evades our immune defenses
(Monash University) Monash University, Australia, researchers have discovered a key way that one of the world's deadliest pathogens, Ebola virus, evades the immune system. Understanding this process provides new potential targets for the future development of anti-viral therapies for a disease that killed over 11,000 people in an outbreak in West Africa between 2014 and 2016, with mortality rates in past outbreaks of 25% to 90%. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Genome study reveals East Asian coronavirus epidemic 20,000 years ago
(Queensland University of Technology) An international study has discovered a coronavirus epidemic broke out in the East Asia region more than 20,000 years ago, with traces of the outbreak evident in the genetic makeup of people from that area. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

No lab required: New technology can diagnose infections in minutes
(McMaster University) Engineering, biochemistry and medical researchers at McMaster University have combined their skills to create a hand-held rapid test for bacterial infections that can produce accurate, reliable results in less than an hour, eliminating the need to send samples to a lab. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Examining association of COVID-19 vaccination, facial nerve palsy
(JAMA Network)What The Study Did:Researchers found no association between recent vaccination with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine and risk of facial nerve palsy. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Association of COVID-19 pandemic with estimated life expectancy by race/ethnicity
(JAMA Network)What The Study Did: Researchers estimated the change in life expectancy associated with the COVID-19 pandemic in the United States by race/ethnicity. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Outcomes for COVID-19 patients 1 year after loss of smell
(JAMA Network)What The Study Did: Patients with COVID-19-related loss of smell were evaluated for one year after the diagnosis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Incidence of bell palsy in patients with COVID-19
(JAMA Network)What The Study Did:The incidence of Bell palsy among patients with COVID-19 was compared with individuals vaccinated against the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Study suggests scientists may need to rethink which genes control aging
(NIH/National Institute of Neurological Disorders and Stroke) National Institutes of Health researchers fed fruit flies antibiotics and monitored the lifetime activity of hundreds of genes that scientists have traditionally thought control aging. To their surprise, the antibiotics not only extended the lives of the flies but also dramatically changed the activity of many of these genes. Their results suggested that only about 30% of the genes traditionally associated with aging set an animal's internal clock while the rest reflect the body's response to bacteria. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Streptococcus pneumoniae sticks to dying lung cells, worsening secondary infection following flu
(University of Alabama at Birmingham) Researchers have found a further reason for the severity of dual infection by influenza and Streptococcus pneumonia -- a new virulence mechanism for a surface protein on the pneumonia-causing bacteria S. pneumoniae. This insight comes 30 years after discovery of that surface protein, called pneumococcal surface protein A. This mechanism had been missed in the past because it facilitates bacterial adherence only to dying lung epithelial cells, not to living cells. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Demystifying COVID-19
(Bentham Science Publishers) This book provides the reader a comprehensive understanding of the disease, its diagnosis and treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Clinical and pre-clinical antimicrobial drug development
(Bentham Science Publishers) The ninth volume of 'Frontiers in Anti-Infective Drug Discovery' discusses clinical and pre-clinical antimicrobial drug development, it also focuses on drugs to treat leishmaniosis and dengue fever. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Decoding humans' survival from coronaviruses
(University of Adelaide) An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Repurposing rheumatology drugs for COVID-19
(European Alliance of Associations for Rheumatology) COVID-19 can be mild, or even without symptoms at all. But it can also cause severe disease, leading to respiratory problems, organ failure, and death. Research on the immune mechanisms involved in people with severe COVID-19 has shown that they have widespread inflammation. Early on in the pandemic, several immunomodulatory anti-inflammatory treatments commonly used in people with rheumatic and musculoskeletal diseases (RMDs) were proposed as possible options for people with severe COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Spreading of infections = need for collaboration between biology and physics
(University of Copenhagen - Faculty of Science) Researchers at the Niels Bohr Institute, University of Copenhagen, together with epidemiologist Lone Simonsen from Roskilde University form part of the panel advising the Danish government on how to tackle the different infection-spreading situations we have all seen unfold over the past year. Researchers have modelled the spread of infections under a variety of scenarios, and the Coronavirus has proven to not follow the older models of disease spreading. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Versatile, fast and reliable SARS-CoV-2 antibody assay
(Technical University of Munich (TUM)) During the continued progression of the Corona pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies - either through infection or vaccination. Researchers at the Technical University of Munich (TUM) have now developed such a rapid antibody test. It provides the result in only eight minutes; the aim is to further reduce the process time to four minutes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Case report: Remdesivir induced dangerously low heart rate in COVID-19 patient
(Elsevier) After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment. The case is discussed in Heart Rhythm Case Reports, an official journal of the Heart Rhythm Society, published by Elsevier. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Cutaneous reactions after mRNA COVID-19 vaccines
(JAMA Network) What The Study Did: Hospital employees were surveyed about symptoms such as a rash, itching, hives or swelling around the face after receiving a messenger RNA COVID-19 vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Skin reactions after COVID-19 vaccination: Rare, uncommonly recur after second dose
(Massachusetts General Hospital) Skin problems after a first mRNA COVID-19 vaccine dose occurred in 1.9% of surveyed employees from hospital system Mass General Brigham. Among employees who experienced a skin reaction to the first dose, 83% had no recurrence of symptoms following the second dose. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Pandemic drives largest decrease in US life expectancy since 1943
(Virginia Commonwealth University) US life expectancy decreased by 1.87 years between 2018 and 2020, according to research publishing June 23 in The BMJ from Virginia Commonwealth University, the University of Colorado Boulder and the Urban Institute. The numbers are worse for people of color. On average, whereas life expectancy among white Americans decreased by 1.36 years in 2020, it decreased by 3.25 years in Black Americans and 3.88 years in Hispanic Americans. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

COVID-19 disruptions in sub-Saharan Africa will have substantial health consequences
(Harvard T.H. Chan School of Public Health) The COVID-19 pandemic poses substantial indirect risks to sub-Saharan African countries with fragile health systems and high levels of poverty, malnutrition, and other infectious diseases. New survey data from Burkina Faso, Ethiopia, and Nigeria provides evidence for public policy to mitigate against nutrition, health, social, and economic impacts of COVID-19 as the pandemic continues to spread on the continent. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Long COVID symptoms likely caused by Epstein-Barr virus reactivation
(World Organization) Epstein-Barr virus (EBV) reactivation may be the cause of previously unexplained long COVID symptoms -- such as fatigue, brain fog, and rashes -- that occur in approximately 30% of patients after recovery from initial COVID-19 infection. The first evidence linking EBV reactivation to long COVID, as well as an analysis of long COVID prevalence, is outlined in a new long COVID study published in the journal Pathogens. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

NIH scientists describe 'multi-kingdom dialogue' between internal, external microbiota
(NIH/National Institute of Allergy and Infectious Diseases) National Institutes of Health scientists and their collaborators have identified an internal communication network in mammals that may regulate tissue repair and inflammation, providing new insights on how diseases such as obesity and inflammatory skin disorders develop. The new research is published in Cell. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Concepts from physics explain importance of quarantine to control spread of COVID-19
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) The central idea of the study was an analogy between concepts in magnetism and epidemiology in which electron interaction is compared with interaction among people. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

NIH begins study of COVID-19 vaccination during pregnancy and postpartum
(NIH/National Institute of Allergy and Infectious Diseases) A new observational study has begun to evaluate the immune responses generated by COVID-19 vaccines administered to pregnant or postpartum people. Researchers will measure the development and durability of antibodies against SARS-CoV-2, the virus that causes COVID-19, in people vaccinated during pregnancy or the first two postpartum months. Researchers also will assess vaccine safety and evaluate the transfer of vaccine-induced antibodies to infants across the placenta and through breast milk. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

New class of compounds found to block coronavirus reproduction
(NYU Langone Health / NYU Grossman School of Medicine) A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help it spread also makes it vulnerable to a new class of drug candidates, a new study finds. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Research provides a roadmap to HIV eradication via stem cell therapy
(University of California - Davis Health) A groundbreaking study found that stem cells reduce the amount of virus causing AIDS, boost the body's antiviral immunity, and restore the gut's lymphoid follicles damaged by HIV. It provided a roadmap for multi-pronged HIV eradication strategies. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Had COVID-19? One vaccine dose enough; boosters for all, study says
(American Chemical Society) Two mRNA vaccines against COVID-19 have proven safe and effective in clinical trials, as well as in the millions of people who have been vaccinated so far. But how prior SARS-CoV-2 infection affects vaccine response, and how long that response lasts, are still uncertain. Now, a new study in ACS Nano supports increasing evidence that people who had COVID-19 need only one vaccine dose, and that boosters could be necessary for everyone in the future. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Low-cost method for finding new coronavirus variants
(Karolinska Institutet) Researchers at Karolinska Institutet in Sweden have developed a technology for cost-effective surveillance of the global spread of new SARS-CoV-2 variants. The technique is presented in the scientific journal Nature Communications. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Research may help identify more dangerous strains of the virus that causes COVID-19
(Wiley) Viral mutations during the COVID-19 pandemic could cause the SARS-CoV-2 virus to become more dangerous. A new study published in Genetic Epidemiology has examined the genetic code of SARS-CoV-2 viruses that have infected patients, looking for links between different mutations and patient deaths. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

Methodology from GWAS accurately flags more deadly SARS-CoV-2 variant
(Harvard T.H. Chan School of Public Health) Using genome-wide association studies (GWAS) methodology to analyze whole-genome sequencing data of SARS-CoV-2 mutations and COVID-19 mortality data can identify highly pathogenic variants of the virus that should be flagged for containment, according to Harvard T.H. Chan School of Public Health and MIT researchers. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news

SARS-CoV-2 positivity, mask utilization among health care workers
(JAMA Network) What The Study Did: Researchers report their study found no association in SARS-CoV-2 positivity rates among health care workers wearing respirator masks compared with medical masks when performing nonaerosolizing routine patient care. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

Tree pollen carries SARS-CoV-2 particles farther, facilitates virus spread
(American Institute of Physics) A study on the role of microscopic particles in virus transmission suggests pollen is nothing to sneeze at. In Physics of Fluids, researchers investigate how pollen facilitates the spread of an RNA virus like the COVID-19 virus. The study draws on cutting-edge computational approaches for analyzing fluid dynamics to mimic the pollen movement from a willow tree, a prototypical pollen emitter. Airborne pollen grains contribute to the spread of airborne viruses, especially in crowded environments. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

More than 16 million Americans undiagnosed with COVID-19 during first wave, estimates antibody analysis
(American Association for the Advancement of Science) As many as 16.8 million Americans had undiagnosed SARS-CoV-2 infections - 5 times the rate of diagnosed infections - by the end of July of 2020, according to an analysis of antibodies from more than 8,000 previously undiagnosed adults collected during the pandemic's first wave. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

Vaccine side effects should be welcomed as a sign of efficacy, immunologists say in new focus
(American Association for the Advancement of Science) The rapid development of safe and efficacious vaccines against SARS-CoV-2 has offered hope that the global COVID-19 pandemic may soon be under control. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

Scientists identify combination of biological markers associated with severe dengue
(eLife) Researchers have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

Partisanship guided Americans' personal safety decisions early in the pandemic
(Brown University) Results from a new study show that many Americans remain fiercely loyal to their like-minded communities, even when their health is on the line -- an important lesson for future pandemics. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

Attention anti-vaccinators: Skin reactions to mRNA COVID-19 vaccines are no cause for alarm
(Elsevier) Vivid photos of the red 'COVID arm' rash and reports of facial swelling in patients who have received dermatological fillers after Pfizer-BioNTech or Moderna vaccination for COVID-19 may increase patients' concerns about mRNA vaccine side effects and contribute to vaccine hesitancy. A comprehensive review in Clinics in Dermatology, conducted by University of Connecticut School of Medicine researchers and published by Elsevier, confirms that almost all cutaneous reactions are largely self-limited and should not discourage getting the vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

Expanded prevent COVID U study also includes adults 18-29 who are not affiliated with a university
(Public Relations Pacific LLC) The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

Study provides MIS-C treatment guidance
(Louisiana State University Health Sciences Center) An analysis conducted by a group of investigators including Tamara Bradford, MD, Associate Professor of Pediatrics at LSU Health New Orleans School of Medicine, found that children and adolescents with Multisystem inflammatory syndrome in children (MIS-C) initially treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

WVU research finds 'excess deaths' in Amish and Mennonite communities during pandemic
(West Virginia University) New research from WVU sociologists suggests that the Amish population saw " excess deaths " in 2020 in the midst of the COVID-19 pandemic. Researchers theorize distrust in preventative medicine and history of religious persecution played a role in the death spike. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2021 Category: Infectious Diseases Source Type: news

Experiences of family members of patients with severe COVID-19 who died in ICUs in France
(JAMA Network) What The Study Did: This qualitative study reports that, in the midst of a major public health crisis, the erosion of family-centered care practices was associated with a dramatic impact on the experiences of family members of patients who died. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news

Association between race, COVID-19 outcomes among children in England
(JAMA Network) What The Study Did: Results of this study suggest race-specific disparities in SARS-CoV-2 testing and COVID-19 hospital outcomes seen in adults also exist among children, after accounting for several clinical and sociodemographic factors thought to play a role in the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news

Using birthdays to assess association between social gatherings, COVID-19 risk
(JAMA Network) What The Study Did: Using administrative healthcare data on 2.9 million households, this study suggests that events that lead to small and informal social gatherings, such as birthdays, and in particular, children's birthdays, are a potentially important source in SARS-CoV-2 transmission. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news

Association of changes in seasonal respiratory virus activity, antibiotic prescriptions with COVID-19 pandemic
This study demonstrated a decrease in respiratory virus detections and a decline in antibiotic prescribing rates for respiratory tract infections during the COVID-19 pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news

Birthdays and COVID-19
(Harvard Medical School) Risk of SARS-CoV-2 infection increased 30% for households with a recent birthday in counties with high rates of COVID-19, but no such jumps seen in areas with low rates of infection. Findings suggest informal social gatherings such as birthday parties played role in infection spread at the height of the coronavirus pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news

The paths through which COVID-19 spread across Brazil
(Associa ç ã o Alberto Santos Dumont para Apoio à Pesquisa) A multidisciplinary analysis by a group of Brazilian scientists, published on-line in the journal Scientific Reports on June 21, 2021, revealed that three major factors accounted for the geographic spread of SARS-COV-2 across Brazil, as well as the massive flow of people in search of hospital care throughout the country, during the first wave of the pandemic in 2020. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news

Keeping a vigilant watch on SARS-CoV-2
(King Abdullah University of Science& Technology (KAUST)) New lateral flow test Vigilant is cheaper, easier to use and as reliable as the current gold standard PCR test for diagnosing SARS-CoV-2 infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news

Significant inequalities observed in popular Liverpool 'mass testing' pilot
(University of Liverpool) A study by the University of Liverpool has shown that while asymptomatic COVID-19 testing in Liverpool was popular, significant inequalities were evident between those who got tested and those who didn't. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news